X

Vanta Bioscience Ltd Stock Analysis

Small Cap
Evaluated by 33 users | BSE: 540729 | NSE: |
Miscellaneous
Vanta Bioscience (VBS) was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name ‘Vanta Bioscience Private Limited’. Their Company was...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 00.62%5.47%6.2%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 03.912.113.7
Y-o-Y Gr. Rt.-NA211.3%13.6%
Adjusted EPS (Rs.) 0-0.020.871.43
Y-o-Y Gr. Rt.-NANA64.4%
Book Value per Share (Rs.) 16.8728.9635.2437.14
Adjusted Net Profit 000.60.9
Net Op. Cash Flow (Rs. Cr.) -0.3-6.8-0.13.2
Debt to Cash Flow from Ops -28.38-1.66-215.714.46
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Vanta Bioscience Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NANANA13.6%
Adjusted EPS NANANA64.4%
Book Value per Share 0030.15.4
Share Price - - 46.2% 74%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 0-0.082.833.95
Operating Profit Margin (%) 026.6127.2431.45
Net Profit Margin (%) 0-0.244.556.57
Debt to Equity 1.220.670.60.6
Working Capital Days 0235251390
Cash Conversion Cycle 0141193319
Entity Percentage Holding
Promoters 69.93%
Non-Institutions 30.07%
Pledged *0.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Data is not available for this company.

Data is not available for this company

Vanta Bioscience (VBS) was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name ‘Vanta Bioscience Private Limited’. Their Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was

Vanta Bioscience (VBS) was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name ‘Vanta Bioscience Private Limited’. Their Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to ‘Vanta Bioscience Limited’ and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017.

One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.

Business area of the company

The company is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition they also provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.

Major Events & Milestones:

  • 2016: Incorporation of the Company.
  • 2017:  The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as - Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601 201.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback